We are live on ! Find out more
VRNA

Verona Pharma

Delisted

VRNA was delisted on the 6th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$23.9M – – –
NMC
2
NEA Management Company
Maryland
$21.4M – – –
RCM
3
RA Capital Management
Massachusetts
$21.4M – – –
Wellington Management Group
4
Wellington Management Group
Massachusetts
$16M +$211K +49,364 +1%
PA
5
Perceptive Advisors
New York
$12.2M -$552K -129,157 -4%
VC
6
Vivo Capital
California
$11.5M – – –
A
7
Abingworth
United Kingdom
$10.2M +$4 +1 +0%
ACM
8
Aisling Capital Management
New York
$5.58M – – –
FCMI
9
Foresite Capital Management III
California
$4.66M – – –
SB
10
Samsara BioCapital
California
$4.66M – – –
FFM
11
Fairmount Funds Management
Pennsylvania
$3.88M – – –
NHAS
12
Novo Holdings A/S
Denmark
$3.19M – – –
TCM
13
Tekla Capital Management
Massachusetts
$3.15M – – –
WP
14
Woodline Partners
California
$2.1M +$2.14M +501,458 New
VP
15
venBio Partners
California
$678K – – –
SSA
16
Schonfeld Strategic Advisors
New York
$227K -$17.5K -4,100 -7%
IC
17
Ikarian Capital
Texas
$200K +$1.28M +300,000 New
DADC
18
D.A. Davidson & Co
Montana
$186K -$15K -3,500 -7%
BFM
19
Boothbay Fund Management
New York
$160K +$164K +38,280 New
Renaissance Technologies
20
Renaissance Technologies
New York
$118K +$121K +28,200 New
FA
21
Forefront Analytics
Pennsylvania
$112K -$36.2K -8,460 -24%
HSBC Holdings
22
HSBC Holdings
United Kingdom
$69K – – –
Geode Capital Management
23
Geode Capital Management
Massachusetts
$60K – – –
IIA
24
IPG Investment Advisors
California
$50K – – –
Goldman Sachs
25
Goldman Sachs
New York
$49K +$49.6K +11,593 New